Weight-Loss Drug ETFs Generate Skinnier Returns Than Expected

finance.yahoo.com/news/weight-loss-drug-etfs-generate-100500722.html

In This Article:
GLP-1 investors haven’t gained as much as expected from others’ losses.
Since the FDA approved Wegovy, also known as semaglutide, as an injectactable treatment to help people manage their weight, several exchange-traded funds tracking the performance of the company and…

This story appeared on finance.yahoo.com, 2025-06-11 10:05:00.
The Entire Business World on a Single Page. Free to Use →